Dopamine and 5-HT receptor sensitivity does not correlate with neostriatal dopamine or 5-HT content

Acta Neurobiologiae Experimentalis

Volumn 56, Issue 1, 1996, Pages 21-28

  Kostrzewa, Richard M ^a   Brus, Ryszard ^b   Perry, K W ^c   Fuller, R W ^c  

^a East Tennessee State University   (United States)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT receptors; 6 hydroxydopamine; dopamine; dopamine receptors; neostriatum; oral dyskinesias; receptor supersensitivity; serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DESIPRAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; KETANSERIN; MIANSERIN; OXIDOPAMINE; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BEHAVIOR; BRAIN DEVELOPMENT; CONFERENCE PAPER; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; NEOSTRIATUM; NEWBORN; NONHUMAN; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION;

ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FEMALE; NEOSTRIATUM; OXIDOPAMINE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SYMPATHOLYTICS;

EID: 0029918078     PISSN: 00651400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Breese G.R., Baumeister A.A., McCown T.J., Emerick S.G., Frye G.D., Crotty K., Mueller R.A. (1984) Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J. Pharmacol. Exp. Ther. 231: 343-354.
2. Breese G.R., Baumeister A., Napier T.C., Frye G.D., Mueller R.A. (1985a) Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 235: 287-295.
3. 2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J. Pharmacol. Exp. Ther. 240: 167-176.
4. Breese G.R., Napier T.C., Mueller R.A. (1985b) Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally-lesioned rats. J. Pharmacol. Exp. Ther. 234: 447-455.
5. 1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. J. Neurosci. 9: 125-133.
6. Gerfen C.R., Young W.S. (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hydridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460: 161-167.
7. Gong L., Kostrzewa R.M. (1992) Supersensitized oral responses to a serotonin agonist in neonatal 6-OHDA-treated rats. Pharmacol. Biochem. Behav. 41: 621-623.
8. Gong L., Kostrzewa R.M., Fuller R.W., Perry K.W. (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J. Pharmacol. Exp. Ther. 261: 1000-1007.
9. Gong L., Kostrzewa R.M., Perry K.W., Fuller R.W. (1993) Dose-related effects of a neonatal 6-OHDA lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Dev. Brain Res. 76: 233-238.
10. 1 receptors. Europ. J. Pharmacol. 203: 115-120.
11. Kostrzewa R.M. (1995) Dopamine receptor supersensitivity. Neurosci. Biobehav. Rev. 19: 1-17.
12. Kostrzewa R.M., Brus R., Perry K.W., Fuller R.W. (1993) Age-dependence of a 6-hydroxydopamine lesion on SKF 38393- and m-chlorophenylpiperazine-induced oral activity responses of rats. Dev. Brain Res. 76: 87-93.
13. 1 receptors mediate enhanced oral activity after neonatal 6-OHDA. Pharmacol. Biochem. Behav. 39: 677-682.
14. Plech A., Brus R., Kalbfleisch J.H., Kostrzewa R.M. (1995) Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats. Psychopharmacol. 119: 466-473.
15. 1 stimulation. Life Sci. 33: 2479-2482.
16. 1 mediated oral dyskinesia. Life Sci. 39: 29-35.
17. Stewart B.R., Jenner P., Marsden C.D. (1989) Induction of purposeless chewing behaviour in rats by 5-HT agonist drags. Eur. J. Pharmacol. 162:101-107.
18. Waddington J.L. (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology (Berlin) 101: 431-447.